UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
SEC
File Number: 000-23016
(Check one): ý Form 10-K Form 20-F
Form 11-K Form 10-Q Form 10-D Form N-SAR Form
N-CSR
For
Period Ended: December 31,
2009
Transition Report on Form 10-K
Transition Report on Form 20-F
Transition Report on Form 11-K
Transition Report on Form 10-Q
Transition Report on Form N-SAR
For the
Transition Period Ended:
_____________________________________________________
Read
Instruction (on back page) Before Preparing Form. Please Print or
Type.
Nothing
in this form shall be construed to imply that the Commission
has
verified any information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Medifast,
Inc.
Full Name
of Registrant
Former
Name if Applicable
11445 Cronhill
Dr.
Address
of Principal Executive Office (Street and
Number)
Owings
Mills, MD 21117
City,
State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate) ý
(a) The
reason described in reasonable detail in Part III of this form could not be
eliminated without unreasonable effort or expense;
|
|
(b) The
subject annual report, semi-annual report, transition report on Form 10-K,
Form 20-F,
|
|
Form
11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q or subject
distribution report on Form 10-D, or portion thereof, will be filed on or
before the fifth calendar day following the prescribed due date;
and
|
|
|
(c) The
accountant’s statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR,
or the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach extra Sheets if Needed)
The
registrant is unable to file its Annual Report on Form 10-K for the year ended
December 31, 2009, within the prescribed time period because the information
required for an accurate and full completion of the report, including but not
limited to the financial statements that form a part thereof, could not be
provided within the prescribed time period without unreasonable effort or
expense. The registrant expects to file its Annual Report on Form
10-K as soon as practicable, and in no event later than the fifteenth calendar
day following the prescribed due date.
PART
IV — OTHER INFORMATION
(1) Name
and telephone number of person to contact in regard to this
notification
Michael
S. McDevitt
|
(410)
504-8106
|
(Name)
|
(Area
Code) (Telephone Number) |
(2) Have
all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was
required to file such report(s) been filed ? If answer is no, identify
report(s). Yes x No o
Amendment
to Annual Report for fiscal year ended December 31, 2008 on Form
10-K.
(3) Is it
anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
Yes o
No x
If so,
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Medifast,
Inc.
(Name of
Registrant as Specified in Charter)
has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
Date March 16,
2010
|
By:
|
/s/ Michael
S. McDevitt |
|
|
|
Chief
Executive Officer |
|